| Net Cash Provided by (Used in) Operating Activities |
$33,708,000 |
USD |
204% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,026,000 |
USD |
42% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$895,000 |
USD |
-110% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
91,719,000 |
shares |
0.97% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$34,555,000 |
USD |
154% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$109,926,000 |
USD |
-8.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,513,000 |
USD |
42% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$225,000 |
USD |
-25% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$82,528,000 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$23,954,000 |
USD |
114% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$42,431,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$31,689,000 |
USD |
152% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$4,606,000 |
USD |
5.1% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.08 |
pure |
-11% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$7,735,000 |
USD |
453% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$42,155,000 |
USD |
41% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
99,820,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Payments |
$6,000,000 |
USD |
7.1% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$182,185,000 |
USD |
4% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$930,000 |
USD |
6.5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$82,303,000 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$10,769,000 |
USD |
1.6% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$5,524,000 |
USD |
0.15% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |